ReviewFrontiers in cellular and infection microbiology2023

Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs.

Yuzhen Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.